Subscribe To
Rocket pharmaceuticals: promising gene therapy play with discounted entry point
Rocket Pharmaceuticals stock trades at ~$19.5 today - back in December 2021 it had hit highs of >$60. The highs were achieved when Rocket's in vivo ge...
February 16, 2023, 12:32 pm
Volitionrx says nu.q vet cancer test now available for pre-order at the point-of-care through heska corporation
VolitionRx (NYSE-A:VNRX) has announced its Nu.Q Vet Cancer Test is now available for pre-order to veterinarians at the point-of-care through Heska Co...
February 16, 2023, 8:51 am
Seattle genetics (sgen) reports q4 loss, tops revenue estimates
Seattle Genetics (SGEN) delivered earnings and revenue surprises of 21.57% and 9.35%, respectively, for...
February 15, 2023, 6:49 pm
Adaptive biotechnologies reports fourth quarter and full year 2022 financial results
SEATTLE, Feb. 14, 2023 (GLOBE NEWSWIRE) — Adaptive Biotechnologies Corporation (“Adaptive Biotechnologies”) (Nasdaq: ADPT), a commercial stage b...
February 14, 2023, 9:05 pm
Regenerative medicine market size worth usd 40,885.32 million by 2030 at 19.70% cagr – report by market research future (mrfr)
Regenerative Medicine Market Trends and Insights by Type (Cell Therapy, Gene Therapy, Tissue Engineering, Small Molecule & Biologic), by Material (Syn...
February 13, 2023, 2:50 pm
Creating a healthy home to reduce heart disease risk
Genetic factors, lifestyle choices, or environmental exposures can cause it. Recognizable forms of hear...
February 11, 2023, 5:44 am
Seqll stock rockets on heavy volume again, in wake of 2-year development pact with fbi
Shares of SeqLL Inc. SQL, -38.69% more than doubled on heavy volume ahead of Friday's open, in the wake of the g...
February 10, 2023, 9:21 am
This genetics stock could have massive long-term potential
This healthcare company isn't without risk but is doing a good job executing on its vision....
February 10, 2023, 6:12 am
Ultragenyx to host conference call for fourth quarter and full-year 2022 financial results and corporate update
NOVATO, Calif., Feb. 09, 2023 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the developmen...
February 9, 2023, 4:01 pm
eneti inc. (neti) q4 2022 earnings call transcript
eneti Inc. (NYSE:NETI ) Q4 2022 Earnings Conference Call February 9, 2023 9:00 AM ET Company Participan...
February 9, 2023, 1:57 pm
Myriad genetics to participate in upcoming healthcare conferences
SALT LAKE CITY, Feb. 09, 2023 (GLOBE NEWSWIRE) — Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in g...
February 9, 2023, 12:15 pm
eneti (neti) beats q4 earnings and revenue estimates
eneti (NETI) delivered earnings and revenue surprises of 366.67% and 31.80%, respectively, for the quar...
February 9, 2023, 11:20 am
Fulcrum therapeutics to participate at the upcoming svb securities global biopharma conference
CAMBRIDGE, Mass., Feb. 08, 2023 (GLOBE NEWSWIRE) — Fulcrum Therapeutics, Inc.® (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused o...
February 8, 2023, 10:00 pm
23andme stock jumps more than 12% on raised 2023 guidance
Shares of 23andMe Holding Co. ME, -0.40% rallied more than 12% in the extended session Wednesday after the gen...
February 8, 2023, 4:50 pm
Design therapeutics to participate in the svb securities virtual global biopharma conference
CARLSBAD, Calif., Feb. 08, 2023 (GLOBE NEWSWIRE) — Design Therapeutics, Inc. (Nasdaq: DSGN), a clinical-stage biotechnology company developing treat...
February 8, 2023, 11:30 am
Why is genetic technologies (gene) stock up 173% today?
Genetic Technologies (NASDAQ: GENE ) stock is taking off on Friday as the company prepares for new canc...
February 3, 2023, 8:35 am
Reneo pharmaceuticals to participate in svb securities global biopharma conference
IRVINE, Calif., Feb. 02, 2023 (GLOBE NEWSWIRE) — Reneo Pharmaceuticals, Inc. (NASDAQ: RPHM), a clinical stage pharmaceutical company focused on the ...
February 2, 2023, 12:35 pm
Eye dna synthesis advances in active biotech etf arkg
It's hard to imagine it now, but at the turn of the millennium, the big advancement in technology was not the latest phone app, it was the Human Genom...
February 1, 2023, 2:38 pm
23andme to report fy2023 third quarter financial results
SOUTH SAN FRANCISCO, Calif., Jan. 26, 2023 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME) (23andMe), a leading human g...
January 26, 2023, 4:05 pm
Goodbody health to offer multi-cancer screening services via liquid biopsy test
Goodbody Health Ltd (AQSE:GDBY, OTCQB:GDBYF) said its network of UK clinics will start offering multi-cancer screening service, as part of a partnersh...
January 26, 2023, 10:03 am